In vitro analysis showed that tumor-specific CD4+ and CD8+ IFN-γ-secreting cells could be efficiently expanded from immunized mice, suggesting that the T helper 1 response is involved in tumor rejection and can kill tumor cells. Here, IFNG is linked to neoplasm.